Applied DNA Sciences (APDN) said Tuesday that the City University of New York has extended its health services contract for COVID-19 testing and vaccine...
Applied DNA Sciences (APDN) said Monday that it closed a public offering of 3 million shares, together with series A warrants to purchase up to 3 million...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 8.33% and 19.33%,...
|Address||50 Health Sciences Drive|
Stony Brook, New York 11790
|Number of Employees||59|
|Recent SEC Filing||08/11/202210-Q|
|Chairman, President & Chief Executive Officer||James A. Hayward|
|Chief Operating Officer||Judy Murrah|
|Chief Financial Officer & Controller||Beth M. Jantzen|
|Associate Director-Production||Frank Cipriani|
|52 Week Range||$0.62 - 7.35|
|Market Capitalization||$44.3 M|
|Shares Outstanding||12.0 M|
|Industry||Biotechnology||Next Earnings Announcement||12/08/2022|
|Call Open Interest (1d)*|
|Put Open Interest (1d)*|
|Call Volume (1d)*|
|Put Volume (1d)*|
|Put Call Open Interest Ratio (1d)*|
|Put Call Volume Ratio (1d)*|
|* Data delayed by up to 15 minutes|
|Price / Earnings||N/A|
|Earnings per Share||-$1.88|
|Beta vs. S&P 500||N/A|
|Net Profit Margin||-95.93%|
|Return on Equity||-135.14%|